176 related articles for article (PubMed ID: 22748679)
1. [The recurrence of facial basal cell carcinoma in patients treated at the Head and Neck Surgery Ward and Laryngological Oncology Clinic of the Greater Poland Cancer Centre in the years 2007-2010].
Pazdrowski J; Dańczak-Pazdrowska A; Golusiński P; Szybiak B; Silny W; Golusiński W
Otolaryngol Pol; 2012; 66(3):185-90. PubMed ID: 22748679
[TBL] [Abstract][Full Text] [Related]
2. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
[TBL] [Abstract][Full Text] [Related]
3. Interventions for basal cell carcinoma of the skin.
Thomson J; Hogan S; Leonardi-Bee J; Williams HC; Bath-Hextall FJ
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD003412. PubMed ID: 33202063
[TBL] [Abstract][Full Text] [Related]
4. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
6. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
7. Favourable results of Mohs micrographic surgery for basal cell carcinoma.
Gniadecki R; Glud M; Mortensen K; Bang B; Biskup E; Omland SH
Dan Med J; 2015 Dec; 62(12):A5171. PubMed ID: 26621396
[TBL] [Abstract][Full Text] [Related]
8. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia.
Mehrany K; Weenig RH; Pittelkow MR; Roenigk RK; Otley CC
Arch Dermatol; 2004 Aug; 140(8):985-8. PubMed ID: 15313816
[TBL] [Abstract][Full Text] [Related]
9. [Basal cell carcinoma of the nose].
Bonvallot T; Raulo Y; Zeller J; Faivre JM; Horn G; Baruch J
Ann Dermatol Venereol; 1993; 120(3):209-14. PubMed ID: 8239358
[TBL] [Abstract][Full Text] [Related]
10. Management of periocular basal cell carcinoma by Mohs micrographic surgery.
Litwin AS; Rytina E; Ha T; René C; Woodruff SA
J Dermatolog Treat; 2013 Jun; 24(3):232-4. PubMed ID: 22551161
[TBL] [Abstract][Full Text] [Related]
11. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma.
Rowe DE; Carroll RJ; Day CL
J Dermatol Surg Oncol; 1989 Apr; 15(4):424-31. PubMed ID: 2925988
[TBL] [Abstract][Full Text] [Related]
12. Superficial basal cell carcinomas of the head and neck.
Mina MA; Picariello A; Fewkes JL
Dermatol Surg; 2013 Jul; 39(7):1003-8. PubMed ID: 23465089
[TBL] [Abstract][Full Text] [Related]
13. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
14. [The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors].
Breuninger H; Schippert W; Black B; Rassner G
Hautarzt; 1989 Nov; 40(11):693-700. PubMed ID: 2606668
[TBL] [Abstract][Full Text] [Related]
15. Long-term Follow-up of Positive Surgical Margins in Basal Cell Carcinoma of the Face.
Bozan A; Gode S; Kaya I; Yaman B; Uslu M; Akyildiz S; Apaydin F; Ceylan C; Ozturk G
Dermatol Surg; 2015 Jul; 41(7):761-7. PubMed ID: 26050215
[TBL] [Abstract][Full Text] [Related]
16. Single center evidence for the treatment of basal cell carcinoma of the head and neck.
Bertozzi N; Simonacci F; Greco MP; Grignaffini E; Raposio E
Acta Biomed; 2019 Jan; 90(1):77-82. PubMed ID: 30889158
[TBL] [Abstract][Full Text] [Related]
17. Eyelid margin basal cell carcinoma managed with full-thickness en-face frozen section histopathology.
Gill HS; Moscato EE; Seiff SR
Ophthalmic Plast Reconstr Surg; 2014; 30(1):15-9. PubMed ID: 24398481
[TBL] [Abstract][Full Text] [Related]
18. Recurrent basal cell carcinoma after incomplete resection.
Robinson JK; Fisher SG
Arch Dermatol; 2000 Nov; 136(11):1318-24. PubMed ID: 11074691
[TBL] [Abstract][Full Text] [Related]
19. [Contribution of the cryosurgery in the management of xeroderma pigmentosum].
Zghal M; Triki S; Elloumi-Jellouli A; Jbali A; Gargouri H; Benmously R; Souissi R; Chedly I; Brahim EB; Ayed MB; Fenniche S; Mokhtar I
Ann Dermatol Venereol; 2010 Oct; 137(10):605-9. PubMed ID: 20932439
[TBL] [Abstract][Full Text] [Related]
20. Cryosurgery and curettage-cryosurgery for basal cell carcinomas of the mid-face.
Samain A; Boullié MC; Duval-Modeste AB; Joly P
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1291-6. PubMed ID: 25354233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
